P.08.13 REDUCED DOSE AND DURATION OF SORAFENIB TREATMENT ARE ASSOCIATED TO TUMOR PROGRESSION IN PATIENTS WITH HEPATOCELLULAR CARCINOMA

✍ Scribed by F.R. Ponziani; B.E. Annicchiarico; M. Siciliano; C. Barone; M. Basso; V. Cesario; M.C. Campanale; G. Caracciolo; M. Garcovich; M.A. Zocco; G. Gigante; E. Rinninella; G. Sarno; T.A. Di Rienzo; F. D'Aversa; G. Gasbarrini; A. Gasbarrini

• Book ID: 118648600
• Publisher: Elsevier Science
• Year: 2012
• Tongue: English
• Weight: 71 KB
• Volume: 44
• Category: Article
• ISSN: 1590-8658
• DOI: 10.1016/s1590-8658(12)60384-3